Primary Record
Paritaprevir
- In stock
- 9,211 g
- Purity
- 98.4 %
- CAS
- 1216941-48-8
Compound Identifiers & Properties
- CAS
- 1216941-48-8
- PubChem CID
- 45110509
- SMILES
- CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8
- Canonical SMILES
- Cc1cnc(C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@@]3(C(=O)NS(=O)(=O)C3CC3)NC(=O)[C@@H]3C[C@@H](Oc4nc5ccccc5c5ccccc45)CN3C2=O)cn1
Names & Synonyms
- Paritaprevir
- Veruprevir
- Veruprevir anhydrous
- empty
- paritapravir
- paritaprevirum
- ABT-450
- 1216941-48-8
- Veruprevir [INN]
- Paritaprevir [USAN]
- Paritaprevir(ABT-450)
- Paritaprevir dihydrate
- ABT450
- Paritaprevir [USAN:INN]
- RefChem:170090
- OU2YM37K86
- PARITAPREVIR [MI]
- UNII-OU2YM37K86
- PARITAPREVIR [INN]
- ABT 450
- Paritaprevir (ABT-450)
- PARITAPREVIR [VANDF]
- veruprevir (deprecated INN)
- PARITAPREVIR [WHO-DD]
- ATB450
- DTXSID601027922
- orb1304404
- orb1305953
- SCHEMBL3069964
- CHEMBL3391662
- SCHEMBL29359149
- C40H43N7O7S
- CHEBI:85188
- GTPL11273
- AMY6938
- DTXCID501513483
- GLXC-10645
- PARITAPREVIR [ORANGE BOOK]
- VIEKIRAX COMPONENT PARITAPREVIR
- EX-A2278
- Paritaprevir(Veruprevir ABT-450)?
- C40-H43-N7-O7-S
- EBC-27456
- MFCD28411394
- s5404
- AKOS025396424
- ZINC197964623
- CCG-270449
- CS-5051
- DB09297
- NCGC00509859-02
- 1221573-85-8
- AC-33061
- AP178043
- AS-75348
- DA-66492
- HY-12594
- J3.361.353I
- A856320
- A857160
- EN300-21959124
- (2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-6-(5-methylpyrazin-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16atetradecahydrocyclopropa(E)pyrrolo(1,2-a)(1,4)diazacyclopentadecine-14a(5H)-carboxamide
- BRD-K89920762-001-01-4
- Viekirax (ombitasvir + paritaprevir + ritonavir; EU)
- (1S,4R,6S,7Z,14S,18R)-N-cyclopropylsulfonyl-14-[(5-methylpyrazine-2-carbonyl)amino]-2,15-dioxo-18-phenanthridin-6-yloxy-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide
- (2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide
- Cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide, N-(cyclopropylsulfonyl)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-6-[[(5-methyl-2-pyrazinyl)carbonyl]amino]-5,16-dioxo-2-(6-phenanthridinyloxy)-, (2R,6S,12Z,13aS,14aR,16aS)-
- 2-Propenoic acid,3-[4-(dimethylamino)phenyl]-,butyl ester
- B0084-474400
- (2R,6S,13aS,14aR,16aS,Z)-N-(Cyclopropylsulfonyl)-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide
- (1S,4R,6S,7Z,14S,18R)-N-(cyclopropanesulfonyl)-14-(5-methylpyrazine-2-amido)-2,15-dioxo-18-(phenanthridin-6-yloxy)-3,16-diazatricyclo[14.3.0.0,4,6]nonadec-7-ene-4-carboxamide
- (1S,4R,6S,7Z,14S,18R)-N-(cyclopropanesulfonyl)-14-(5-methylpyrazine-2-amido)-2,15-dioxo-18-(phenanthridin-6-yloxy)-3,16-diazatricyclo[14.3.0.0?,?]nonadec-7-ene-4-carboxamide
- (1S,4R,6S,7Z,14S,18R)-N-(cyclopropanesulfonyl)-14-(5-methylpyrazine-2-amido)-2,15-dioxo-18-(phenanthridin-6-yloxy)-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide
- (1S,4R,6S,7Z,14S,18R)-N-(Cyclopropylsulfonyl)-14-[(5-methyl-2-pyrazinyl)carbonylamino]-2,15-dioxo-18-[(phenanthridin-6-yl)oxy]-3,16-diazatricyclo[14.3.0.04,6]nonadeca-7-ene-4-carboxamide
- (1S,4R,6S,7Z,14S,18R)-N-cyclopropylsulfonyl-14-((5-methylpyrazine-2-carbonyl)amino)-2,15-dioxo-18-phenanthridin-6-yloxy-3,16-diazatricyclo(14.3.0.04,6)nonadec-7-ene-4-carboxamide
- (2R,6S,12Z,13aR,14aR,16aS)-N-(cyclopropanesulfonyl)-6-[(5-methylpyrazine-2-carbonyl)amino]-5,16-dioxo-2-[(phenanthridin-6-yl)oxy]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide
- (2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-6-(((5-methyl-2-pyrazinyl)carbonyl)amino)-5,16-dioxo-2-(6-phenanthridinyloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa(e)pyrrolo (1,2-a)(1,4)diazacyclopentadecine-14a(5H)-carboxamide
- (2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-6-{[(5-methylpyrazin-2-yl)carbonyl]amino}-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[E]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide
- Veruprevir|||ABT 450|||(2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide